Target Gene/Pathway Pathway / Gene
Search results
| No. | KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related | KEGG GENES | KEGG DRUG | DrugBank | 指定難病告示番号 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Adrenergic signaling in cardiomyocytes 💬 31 genes, 84 drugs (DrugBank) and 76 diseases |
ADRB1 1件: ADRB1 💬Adrenergic signaling in cardiomyocytes
|
Atenolol Atenolol 💬Adrenergic signaling in cardiomyocytes
| Atenolol | 167 1件: 167 💬1. Adrenergic signaling in cardiomyocytes
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 2 | Adrenergic signaling in cardiomyocytes 💬 31 genes, 84 drugs (DrugBank) and 76 diseases |
ADRB1 1件: ADRB1 💬Adrenergic signaling in cardiomyocytes
|
Nebivolol Nebivolol 💬Adrenergic signaling in cardiomyocytes
| Nebivolol | 017 4件: 17, 85, 113, 167 💬2. Adrenergic signaling in cardiomyocytes
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 3 | Adrenergic signaling in cardiomyocytes 💬 31 genes, 84 drugs (DrugBank) and 76 diseases |
ADRB1 1件: ADRB1 💬Adrenergic signaling in cardiomyocytes
|
Nebivolol hydrochloride Nebivolol hydrochloride 💬Adrenergic signaling in cardiomyocytes
| Nebivolol | 017 4件: 17, 85, 113, 167 💬2. Adrenergic signaling in cardiomyocytes
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 4 | Adrenergic signaling in cardiomyocytes 💬 31 genes, 84 drugs (DrugBank) and 76 diseases |
AGTR1 1件: AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Irbesartan Irbesartan 💬Adrenergic signaling in cardiomyocytes
| Irbesartan | 066 4件: 66, 167, 168, 222 💬4. Adrenergic signaling in cardiomyocytes
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 5 | Adrenergic signaling in cardiomyocytes 💬 31 genes, 84 drugs (DrugBank) and 76 diseases |
AGTR1 1件: AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Losartan potassium Losartan potassium 💬Adrenergic signaling in cardiomyocytes
| Losartan | 017 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬5. Adrenergic signaling in cardiomyocytes
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 6 | Adrenergic signaling in cardiomyocytes 💬 31 genes, 84 drugs (DrugBank) and 76 diseases |
AGTR1 1件: AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Losartan Losartan 💬Adrenergic signaling in cardiomyocytes
| Losartan | 017 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬5. Adrenergic signaling in cardiomyocytes
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 7 | Adrenergic signaling in cardiomyocytes 💬 31 genes, 84 drugs (DrugBank) and 76 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Verapamil hydrochloride Verapamil hydrochloride 💬Adrenergic signaling in cardiomyocytes
| Verapamil | 058 4件: 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 8 | Adrenergic signaling in cardiomyocytes 💬 31 genes, 84 drugs (DrugBank) and 76 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Verapamil Verapamil 💬Adrenergic signaling in cardiomyocytes
| Verapamil | 058 4件: 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 9 | AGE-RAGE signaling pathway in diabetic complications 💬 28 genes, 55 drugs (DrugBank) and 96 diseases |
AGTR1 1件: AGTR1 💬AGE-RAGE signaling pathway in diabetic complications
|
Irbesartan Irbesartan 💬AGE-RAGE signaling pathway in diabetic complications
| Irbesartan | 066 4件: 66, 167, 168, 222 💬9. AGE-RAGE signaling pathway in diabetic complications
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 10 | AGE-RAGE signaling pathway in diabetic complications 💬 28 genes, 55 drugs (DrugBank) and 96 diseases |
AGTR1 1件: AGTR1 💬AGE-RAGE signaling pathway in diabetic complications
|
Losartan potassium Losartan potassium 💬AGE-RAGE signaling pathway in diabetic complications
| Losartan | 017 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬10. AGE-RAGE signaling pathway in diabetic complications
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 11 | AGE-RAGE signaling pathway in diabetic complications 💬 28 genes, 55 drugs (DrugBank) and 96 diseases |
AGTR1 1件: AGTR1 💬AGE-RAGE signaling pathway in diabetic complications
|
Losartan Losartan 💬AGE-RAGE signaling pathway in diabetic complications
| Losartan | 017 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬10. AGE-RAGE signaling pathway in diabetic complications
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 12 | Aldosterone synthesis and secretion 💬 20 genes, 41 drugs (DrugBank) and 61 diseases |
AGTR1 1件: AGTR1 💬Aldosterone synthesis and secretion
|
Irbesartan Irbesartan 💬Aldosterone synthesis and secretion
| Irbesartan | 066 4件: 66, 167, 168, 222 💬12. Aldosterone synthesis and secretion
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 13 | Aldosterone synthesis and secretion 💬 20 genes, 41 drugs (DrugBank) and 61 diseases |
AGTR1 1件: AGTR1 💬Aldosterone synthesis and secretion
|
Losartan potassium Losartan potassium 💬Aldosterone synthesis and secretion
| Losartan | 017 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬13. Aldosterone synthesis and secretion
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 14 | Aldosterone synthesis and secretion 💬 20 genes, 41 drugs (DrugBank) and 61 diseases |
AGTR1 1件: AGTR1 💬Aldosterone synthesis and secretion
|
Losartan Losartan 💬Aldosterone synthesis and secretion
| Losartan | 017 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬13. Aldosterone synthesis and secretion
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 15 | Aldosterone synthesis and secretion 💬 20 genes, 41 drugs (DrugBank) and 61 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Verapamil hydrochloride Verapamil hydrochloride 💬Aldosterone synthesis and secretion
| Verapamil | 058 4件: 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 16 | Aldosterone synthesis and secretion 💬 20 genes, 41 drugs (DrugBank) and 61 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Verapamil Verapamil 💬Aldosterone synthesis and secretion
| Verapamil | 058 4件: 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 17 | Alzheimer disease 💬 59 genes, 132 drugs (DrugBank) and 129 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Verapamil hydrochloride Verapamil hydrochloride 💬Alzheimer disease
| Verapamil | 058 4件: 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 18 | Alzheimer disease 💬 59 genes, 132 drugs (DrugBank) and 129 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Verapamil Verapamil 💬Alzheimer disease
| Verapamil | 058 4件: 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 19 | Amphetamine addiction 💬 25 genes, 58 drugs (DrugBank) and 92 diseases |
CACNA1C 2件: CACNA1C, CACNA1D 💬
|
Verapamil hydrochloride Verapamil hydrochloride 💬Amphetamine addiction
| Verapamil | 058 4件: 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 20 | Amphetamine addiction 💬 25 genes, 58 drugs (DrugBank) and 92 diseases |
CACNA1C 2件: CACNA1C, CACNA1D 💬
|
Verapamil Verapamil 💬Amphetamine addiction
| Verapamil | 058 4件: 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 21 | Apelin signaling pathway 💬 20 genes, 36 drugs (DrugBank) and 77 diseases |
AGTR1 1件: AGTR1 💬Apelin signaling pathway
|
Irbesartan Irbesartan 💬Apelin signaling pathway
| Irbesartan | 066 4件: 66, 167, 168, 222 💬21. Apelin signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 22 | Apelin signaling pathway 💬 20 genes, 36 drugs (DrugBank) and 77 diseases |
AGTR1 1件: AGTR1 💬Apelin signaling pathway
|
Losartan potassium Losartan potassium 💬Apelin signaling pathway
| Losartan | 017 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬22. Apelin signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 23 | Apelin signaling pathway 💬 20 genes, 36 drugs (DrugBank) and 77 diseases |
AGTR1 1件: AGTR1 💬Apelin signaling pathway
|
Losartan Losartan 💬Apelin signaling pathway
| Losartan | 017 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬22. Apelin signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 24 | Arrhythmogenic right ventricular cardiomyopathy 💬 15 genes, 30 drugs (DrugBank) and 28 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Verapamil hydrochloride Verapamil hydrochloride 💬Arrhythmogenic right ventricular cardiomyopathy
| Verapamil | 058 4件: 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 25 | Arrhythmogenic right ventricular cardiomyopathy 💬 15 genes, 30 drugs (DrugBank) and 28 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Verapamil Verapamil 💬Arrhythmogenic right ventricular cardiomyopathy
| Verapamil | 058 4件: 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 26 | Calcium signaling pathway 💬 86 genes, 214 drugs (DrugBank) and 143 diseases |
ADRB1 1件: ADRB1 💬Calcium signaling pathway
|
Atenolol Atenolol 💬Calcium signaling pathway
| Atenolol | 167 1件: 167 💬26. Calcium signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 27 | Calcium signaling pathway 💬 86 genes, 214 drugs (DrugBank) and 143 diseases |
ADRB1 1件: ADRB1 💬Calcium signaling pathway
|
Nebivolol Nebivolol 💬Calcium signaling pathway
| Nebivolol | 017 4件: 17, 85, 113, 167 💬27. Calcium signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 28 | Calcium signaling pathway 💬 86 genes, 214 drugs (DrugBank) and 143 diseases |
ADRB1 1件: ADRB1 💬Calcium signaling pathway
|
Nebivolol hydrochloride Nebivolol hydrochloride 💬Calcium signaling pathway
| Nebivolol | 017 4件: 17, 85, 113, 167 💬27. Calcium signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 29 | Calcium signaling pathway 💬 86 genes, 214 drugs (DrugBank) and 143 diseases |
AGTR1 1件: AGTR1 💬Calcium signaling pathway
|
Irbesartan Irbesartan 💬Calcium signaling pathway
| Irbesartan | 066 4件: 66, 167, 168, 222 💬29. Calcium signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 30 | Calcium signaling pathway 💬 86 genes, 214 drugs (DrugBank) and 143 diseases |
AGTR1 1件: AGTR1 💬Calcium signaling pathway
|
Losartan potassium Losartan potassium 💬Calcium signaling pathway
| Losartan | 017 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬30. Calcium signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 31 | Calcium signaling pathway 💬 86 genes, 214 drugs (DrugBank) and 143 diseases |
AGTR1 1件: AGTR1 💬Calcium signaling pathway
|
Losartan Losartan 💬Calcium signaling pathway
| Losartan | 017 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬30. Calcium signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 32 | Calcium signaling pathway 💬 86 genes, 214 drugs (DrugBank) and 143 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Verapamil hydrochloride Verapamil hydrochloride 💬Calcium signaling pathway
| Verapamil | 058 4件: 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 33 | Calcium signaling pathway 💬 86 genes, 214 drugs (DrugBank) and 143 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Verapamil Verapamil 💬Calcium signaling pathway
| Verapamil | 058 4件: 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 34 | cAMP signaling pathway 💬 66 genes, 189 drugs (DrugBank) and 130 diseases |
ADRB1 1件: ADRB1 💬cAMP signaling pathway
|
Atenolol Atenolol 💬cAMP signaling pathway
| Atenolol | 167 1件: 167 💬34. cAMP signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 35 | cAMP signaling pathway 💬 66 genes, 189 drugs (DrugBank) and 130 diseases |
ADRB1 1件: ADRB1 💬cAMP signaling pathway
|
Nebivolol Nebivolol 💬cAMP signaling pathway
| Nebivolol | 017 4件: 17, 85, 113, 167 💬35. cAMP signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 36 | cAMP signaling pathway 💬 66 genes, 189 drugs (DrugBank) and 130 diseases |
ADRB1 1件: ADRB1 💬cAMP signaling pathway
|
Nebivolol hydrochloride Nebivolol hydrochloride 💬cAMP signaling pathway
| Nebivolol | 017 4件: 17, 85, 113, 167 💬35. cAMP signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 37 | cAMP signaling pathway 💬 66 genes, 189 drugs (DrugBank) and 130 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Verapamil hydrochloride Verapamil hydrochloride 💬cAMP signaling pathway
| Verapamil | 058 4件: 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 38 | cAMP signaling pathway 💬 66 genes, 189 drugs (DrugBank) and 130 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Verapamil Verapamil 💬cAMP signaling pathway
| Verapamil | 058 4件: 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 39 | Carbohydrate digestion and absorption 💬 13 genes, 21 drugs (DrugBank) and 33 diseases |
CACNA1D 1件: CACNA1D 💬Carbohydrate digestion and absorption
|
Verapamil hydrochloride Verapamil hydrochloride 💬Carbohydrate digestion and absorption
| Verapamil | 058 4件: 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 40 | Carbohydrate digestion and absorption 💬 13 genes, 21 drugs (DrugBank) and 33 diseases |
CACNA1D 1件: CACNA1D 💬Carbohydrate digestion and absorption
|
Verapamil Verapamil 💬Carbohydrate digestion and absorption
| Verapamil | 058 4件: 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 41 | Cardiac muscle contraction 💬 17 genes, 20 drugs (DrugBank) and 25 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Verapamil hydrochloride Verapamil hydrochloride 💬Cardiac muscle contraction
| Verapamil | 058 4件: 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 42 | Cardiac muscle contraction 💬 17 genes, 20 drugs (DrugBank) and 25 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Verapamil Verapamil 💬Cardiac muscle contraction
| Verapamil | 058 4件: 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 43 | Cellular senescence 💬 34 genes, 46 drugs (DrugBank) and 96 diseases |
CACNA1D 1件: CACNA1D 💬Cellular senescence
|
Verapamil hydrochloride Verapamil hydrochloride 💬Cellular senescence
| Verapamil | 058 4件: 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 44 | Cellular senescence 💬 34 genes, 46 drugs (DrugBank) and 96 diseases |
CACNA1D 1件: CACNA1D 💬Cellular senescence
|
Verapamil Verapamil 💬Cellular senescence
| Verapamil | 058 4件: 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 45 | cGMP-PKG signaling pathway 💬 49 genes, 132 drugs (DrugBank) and 124 diseases |
ADRB1 1件: ADRB1 💬cGMP-PKG signaling pathway
|
Atenolol Atenolol 💬cGMP-PKG signaling pathway
| Atenolol | 167 1件: 167 💬45. cGMP-PKG signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 46 | cGMP-PKG signaling pathway 💬 49 genes, 132 drugs (DrugBank) and 124 diseases |
ADRB1 1件: ADRB1 💬cGMP-PKG signaling pathway
|
Nebivolol Nebivolol 💬cGMP-PKG signaling pathway
| Nebivolol | 017 4件: 17, 85, 113, 167 💬46. cGMP-PKG signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 47 | cGMP-PKG signaling pathway 💬 49 genes, 132 drugs (DrugBank) and 124 diseases |
ADRB1 1件: ADRB1 💬cGMP-PKG signaling pathway
|
Nebivolol hydrochloride Nebivolol hydrochloride 💬cGMP-PKG signaling pathway
| Nebivolol | 017 4件: 17, 85, 113, 167 💬46. cGMP-PKG signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 48 | cGMP-PKG signaling pathway 💬 49 genes, 132 drugs (DrugBank) and 124 diseases |
AGTR1 1件: AGTR1 💬cGMP-PKG signaling pathway
|
Irbesartan Irbesartan 💬cGMP-PKG signaling pathway
| Irbesartan | 066 4件: 66, 167, 168, 222 💬48. cGMP-PKG signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 49 | cGMP-PKG signaling pathway 💬 49 genes, 132 drugs (DrugBank) and 124 diseases |
AGTR1 1件: AGTR1 💬cGMP-PKG signaling pathway
|
Losartan potassium Losartan potassium 💬cGMP-PKG signaling pathway
| Losartan | 017 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬49. cGMP-PKG signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 50 | cGMP-PKG signaling pathway 💬 49 genes, 132 drugs (DrugBank) and 124 diseases |
AGTR1 1件: AGTR1 💬cGMP-PKG signaling pathway
|
Losartan Losartan 💬cGMP-PKG signaling pathway
| Losartan | 017 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬49. cGMP-PKG signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 51 | cGMP-PKG signaling pathway 💬 49 genes, 132 drugs (DrugBank) and 124 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Verapamil hydrochloride Verapamil hydrochloride 💬cGMP-PKG signaling pathway
| Verapamil | 058 4件: 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 52 | cGMP-PKG signaling pathway 💬 49 genes, 132 drugs (DrugBank) and 124 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Verapamil Verapamil 💬cGMP-PKG signaling pathway
| Verapamil | 058 4件: 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 53 | Chagas disease 💬 31 genes, 56 drugs (DrugBank) and 87 diseases |
ACE 1件: ACE 💬Chagas disease
|
Perindopril erbumine Perindopril erbumine 💬Chagas disease
| Perindopril | 058 4件: 58, 113, 167, 222 💬53. Chagas disease
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 54 | Chagas disease 💬 31 genes, 56 drugs (DrugBank) and 87 diseases |
ACE 1件: ACE 💬Chagas disease
|
Perindopril Perindopril 💬Chagas disease
| Perindopril | 058 4件: 58, 113, 167, 222 💬53. Chagas disease
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 55 | Chagas disease 💬 31 genes, 56 drugs (DrugBank) and 87 diseases |
ACE 1件: ACE 💬Chagas disease
|
Perindopril arginine Perindopril arginine 💬Chagas disease
| Perindopril | 058 4件: 58, 113, 167, 222 💬53. Chagas disease
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 56 | Chemical carcinogenesis - receptor activation 💬 39 genes, 135 drugs (DrugBank) and 134 diseases |
ADRB1 1件: ADRB1 💬Chemical carcinogenesis - receptor activation
|
Atenolol Atenolol 💬Chemical carcinogenesis - receptor activation
| Atenolol | 167 1件: 167 💬56. Chemical carcinogenesis - receptor activation
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 57 | Chemical carcinogenesis - receptor activation 💬 39 genes, 135 drugs (DrugBank) and 134 diseases |
ADRB1 1件: ADRB1 💬Chemical carcinogenesis - receptor activation
|
Nebivolol Nebivolol 💬Chemical carcinogenesis - receptor activation
| Nebivolol | 017 4件: 17, 85, 113, 167 💬57. Chemical carcinogenesis - receptor activation
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 58 | Chemical carcinogenesis - receptor activation 💬 39 genes, 135 drugs (DrugBank) and 134 diseases |
ADRB1 1件: ADRB1 💬Chemical carcinogenesis - receptor activation
|
Nebivolol hydrochloride Nebivolol hydrochloride 💬Chemical carcinogenesis - receptor activation
| Nebivolol | 017 4件: 17, 85, 113, 167 💬57. Chemical carcinogenesis - receptor activation
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 59 | Chemical carcinogenesis - receptor activation 💬 39 genes, 135 drugs (DrugBank) and 134 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Verapamil hydrochloride Verapamil hydrochloride 💬Chemical carcinogenesis - receptor activation
| Verapamil | 058 4件: 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 60 | Chemical carcinogenesis - receptor activation 💬 39 genes, 135 drugs (DrugBank) and 134 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Verapamil Verapamil 💬Chemical carcinogenesis - receptor activation
| Verapamil | 058 4件: 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 61 | Cholinergic synapse 💬 32 genes, 64 drugs (DrugBank) and 81 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Verapamil hydrochloride Verapamil hydrochloride 💬Cholinergic synapse
| Verapamil | 058 4件: 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 62 | Cholinergic synapse 💬 32 genes, 64 drugs (DrugBank) and 81 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Verapamil Verapamil 💬Cholinergic synapse
| Verapamil | 058 4件: 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 63 | Circadian entrainment 💬 23 genes, 39 drugs (DrugBank) and 55 diseases |
CACNA1C 2件: CACNA1C, CACNA1D 💬
|
Verapamil hydrochloride Verapamil hydrochloride 💬Circadian entrainment
| Verapamil | 058 4件: 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 64 | Circadian entrainment 💬 23 genes, 39 drugs (DrugBank) and 55 diseases |
CACNA1C 2件: CACNA1C, CACNA1D 💬
|
Verapamil Verapamil 💬Circadian entrainment
| Verapamil | 058 4件: 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 65 | Coronavirus disease - COVID-19 💬 54 genes, 108 drugs (DrugBank) and 105 diseases |
ACE 1件: ACE 💬Coronavirus disease - COVID-19
|
Perindopril erbumine Perindopril erbumine 💬Coronavirus disease - COVID-19
| Perindopril | 058 4件: 58, 113, 167, 222 💬65. Coronavirus disease - COVID-19
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 66 | Coronavirus disease - COVID-19 💬 54 genes, 108 drugs (DrugBank) and 105 diseases |
ACE 1件: ACE 💬Coronavirus disease - COVID-19
|
Perindopril Perindopril 💬Coronavirus disease - COVID-19
| Perindopril | 058 4件: 58, 113, 167, 222 💬65. Coronavirus disease - COVID-19
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 67 | Coronavirus disease - COVID-19 💬 54 genes, 108 drugs (DrugBank) and 105 diseases |
ACE 1件: ACE 💬Coronavirus disease - COVID-19
|
Perindopril arginine Perindopril arginine 💬Coronavirus disease - COVID-19
| Perindopril | 058 4件: 58, 113, 167, 222 💬65. Coronavirus disease - COVID-19
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 68 | Coronavirus disease - COVID-19 💬 54 genes, 108 drugs (DrugBank) and 105 diseases |
AGTR1 1件: AGTR1 💬Coronavirus disease - COVID-19
|
Irbesartan Irbesartan 💬Coronavirus disease - COVID-19
| Irbesartan | 066 4件: 66, 167, 168, 222 💬68. Coronavirus disease - COVID-19
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 69 | Coronavirus disease - COVID-19 💬 54 genes, 108 drugs (DrugBank) and 105 diseases |
AGTR1 1件: AGTR1 💬Coronavirus disease - COVID-19
|
Losartan potassium Losartan potassium 💬Coronavirus disease - COVID-19
| Losartan | 017 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬69. Coronavirus disease - COVID-19
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 70 | Coronavirus disease - COVID-19 💬 54 genes, 108 drugs (DrugBank) and 105 diseases |
AGTR1 1件: AGTR1 💬Coronavirus disease - COVID-19
|
Losartan Losartan 💬Coronavirus disease - COVID-19
| Losartan | 017 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬69. Coronavirus disease - COVID-19
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 71 | Cortisol synthesis and secretion 💬 15 genes, 36 drugs (DrugBank) and 63 diseases |
AGTR1 1件: AGTR1 💬Cortisol synthesis and secretion
|
Irbesartan Irbesartan 💬Cortisol synthesis and secretion
| Irbesartan | 066 4件: 66, 167, 168, 222 💬71. Cortisol synthesis and secretion
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 72 | Cortisol synthesis and secretion 💬 15 genes, 36 drugs (DrugBank) and 63 diseases |
AGTR1 1件: AGTR1 💬Cortisol synthesis and secretion
|
Losartan potassium Losartan potassium 💬Cortisol synthesis and secretion
| Losartan | 017 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬72. Cortisol synthesis and secretion
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 73 | Cortisol synthesis and secretion 💬 15 genes, 36 drugs (DrugBank) and 63 diseases |
AGTR1 1件: AGTR1 💬Cortisol synthesis and secretion
|
Losartan Losartan 💬Cortisol synthesis and secretion
| Losartan | 017 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬72. Cortisol synthesis and secretion
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 74 | Cortisol synthesis and secretion 💬 15 genes, 36 drugs (DrugBank) and 63 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Verapamil hydrochloride Verapamil hydrochloride 💬Cortisol synthesis and secretion
| Verapamil | 058 4件: 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 75 | Cortisol synthesis and secretion 💬 15 genes, 36 drugs (DrugBank) and 63 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Verapamil Verapamil 💬Cortisol synthesis and secretion
| Verapamil | 058 4件: 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 76 | Cushing syndrome 💬 24 genes, 55 drugs (DrugBank) and 71 diseases |
AGTR1 1件: AGTR1 💬Cushing syndrome
|
Irbesartan Irbesartan 💬Cushing syndrome
| Irbesartan | 066 4件: 66, 167, 168, 222 💬76. Cushing syndrome
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 77 | Cushing syndrome 💬 24 genes, 55 drugs (DrugBank) and 71 diseases |
AGTR1 1件: AGTR1 💬Cushing syndrome
|
Losartan potassium Losartan potassium 💬Cushing syndrome
| Losartan | 017 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬77. Cushing syndrome
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 78 | Cushing syndrome 💬 24 genes, 55 drugs (DrugBank) and 71 diseases |
AGTR1 1件: AGTR1 💬Cushing syndrome
|
Losartan Losartan 💬Cushing syndrome
| Losartan | 017 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬77. Cushing syndrome
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 79 | Cushing syndrome 💬 24 genes, 55 drugs (DrugBank) and 71 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Verapamil hydrochloride Verapamil hydrochloride 💬Cushing syndrome
| Verapamil | 058 4件: 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 80 | Cushing syndrome 💬 24 genes, 55 drugs (DrugBank) and 71 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Verapamil Verapamil 💬Cushing syndrome
| Verapamil | 058 4件: 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 81 | Diabetic cardiomyopathy 💬 28 genes, 48 drugs (DrugBank) and 79 diseases |
ACE 1件: ACE 💬Diabetic cardiomyopathy
|
Perindopril erbumine Perindopril erbumine 💬Diabetic cardiomyopathy
| Perindopril | 058 4件: 58, 113, 167, 222 💬81. Diabetic cardiomyopathy
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 82 | Diabetic cardiomyopathy 💬 28 genes, 48 drugs (DrugBank) and 79 diseases |
ACE 1件: ACE 💬Diabetic cardiomyopathy
|
Perindopril Perindopril 💬Diabetic cardiomyopathy
| Perindopril | 058 4件: 58, 113, 167, 222 💬81. Diabetic cardiomyopathy
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 83 | Diabetic cardiomyopathy 💬 28 genes, 48 drugs (DrugBank) and 79 diseases |
ACE 1件: ACE 💬Diabetic cardiomyopathy
|
Perindopril arginine Perindopril arginine 💬Diabetic cardiomyopathy
| Perindopril | 058 4件: 58, 113, 167, 222 💬81. Diabetic cardiomyopathy
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 84 | Diabetic cardiomyopathy 💬 28 genes, 48 drugs (DrugBank) and 79 diseases |
AGTR1 1件: AGTR1 💬Diabetic cardiomyopathy
|
Irbesartan Irbesartan 💬Diabetic cardiomyopathy
| Irbesartan | 066 4件: 66, 167, 168, 222 💬84. Diabetic cardiomyopathy
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 85 | Diabetic cardiomyopathy 💬 28 genes, 48 drugs (DrugBank) and 79 diseases |
AGTR1 1件: AGTR1 💬Diabetic cardiomyopathy
|
Losartan potassium Losartan potassium 💬Diabetic cardiomyopathy
| Losartan | 017 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬85. Diabetic cardiomyopathy
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 86 | Diabetic cardiomyopathy 💬 28 genes, 48 drugs (DrugBank) and 79 diseases |
AGTR1 1件: AGTR1 💬Diabetic cardiomyopathy
|
Losartan Losartan 💬Diabetic cardiomyopathy
| Losartan | 017 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬85. Diabetic cardiomyopathy
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 87 | Diabetic cardiomyopathy 💬 28 genes, 48 drugs (DrugBank) and 79 diseases |
REN 1件: REN 💬Diabetic cardiomyopathy
|
Aliskiren Aliskiren 💬Diabetic cardiomyopathy
| Aliskiren | 066 3件: 66, 167, 222 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 88 | Diabetic cardiomyopathy 💬 28 genes, 48 drugs (DrugBank) and 79 diseases |
REN 1件: REN 💬Diabetic cardiomyopathy
|
Aliskiren fumarate Aliskiren fumarate 💬Diabetic cardiomyopathy
| Aliskiren | 066 3件: 66, 167, 222 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 89 | Dilated cardiomyopathy 💬 24 genes, 61 drugs (DrugBank) and 88 diseases |
ADRB1 1件: ADRB1 💬Dilated cardiomyopathy
|
Atenolol Atenolol 💬Dilated cardiomyopathy
| Atenolol | 167 1件: 167 💬89. Dilated cardiomyopathy
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 90 | Dilated cardiomyopathy 💬 24 genes, 61 drugs (DrugBank) and 88 diseases |
ADRB1 1件: ADRB1 💬Dilated cardiomyopathy
|
Nebivolol Nebivolol 💬Dilated cardiomyopathy
| Nebivolol | 017 4件: 17, 85, 113, 167 💬90. Dilated cardiomyopathy
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 91 | Dilated cardiomyopathy 💬 24 genes, 61 drugs (DrugBank) and 88 diseases |
ADRB1 1件: ADRB1 💬Dilated cardiomyopathy
|
Nebivolol hydrochloride Nebivolol hydrochloride 💬Dilated cardiomyopathy
| Nebivolol | 017 4件: 17, 85, 113, 167 💬90. Dilated cardiomyopathy
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 92 | Dilated cardiomyopathy 💬 24 genes, 61 drugs (DrugBank) and 88 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Verapamil hydrochloride Verapamil hydrochloride 💬Dilated cardiomyopathy
| Verapamil | 058 4件: 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 93 | Dilated cardiomyopathy 💬 24 genes, 61 drugs (DrugBank) and 88 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Verapamil Verapamil 💬Dilated cardiomyopathy
| Verapamil | 058 4件: 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 94 | Dopaminergic synapse 💬 31 genes, 102 drugs (DrugBank) and 104 diseases |
CACNA1C 2件: CACNA1C, CACNA1D 💬
|
Verapamil hydrochloride Verapamil hydrochloride 💬Dopaminergic synapse
| Verapamil | 058 4件: 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 95 | Dopaminergic synapse 💬 31 genes, 102 drugs (DrugBank) and 104 diseases |
CACNA1C 2件: CACNA1C, CACNA1D 💬
|
Verapamil Verapamil 💬Dopaminergic synapse
| Verapamil | 058 4件: 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 96 | GABAergic synapse 💬 29 genes, 43 drugs (DrugBank) and 55 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Verapamil hydrochloride Verapamil hydrochloride 💬GABAergic synapse
| Verapamil | 058 4件: 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 97 | GABAergic synapse 💬 29 genes, 43 drugs (DrugBank) and 55 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Verapamil Verapamil 💬GABAergic synapse
| Verapamil | 058 4件: 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 98 | Gap junction 💬 26 genes, 97 drugs (DrugBank) and 82 diseases |
ADRB1 1件: ADRB1 💬Gap junction
|
Atenolol Atenolol 💬Gap junction
| Atenolol | 167 1件: 167 💬98. Gap junction
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 99 | Gap junction 💬 26 genes, 97 drugs (DrugBank) and 82 diseases |
ADRB1 1件: ADRB1 💬Gap junction
|
Nebivolol Nebivolol 💬Gap junction
| Nebivolol | 017 4件: 17, 85, 113, 167 💬99. Gap junction
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 100 | Gap junction 💬 26 genes, 97 drugs (DrugBank) and 82 diseases |
ADRB1 1件: ADRB1 💬Gap junction
|
Nebivolol hydrochloride Nebivolol hydrochloride 💬Gap junction
| Nebivolol | 017 4件: 17, 85, 113, 167 💬99. Gap junction
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 101 | Glutamatergic synapse 💬 23 genes, 30 drugs (DrugBank) and 81 diseases |
CACNA1C 2件: CACNA1C, CACNA1D 💬
|
Verapamil hydrochloride Verapamil hydrochloride 💬Glutamatergic synapse
| Verapamil | 058 4件: 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 102 | Glutamatergic synapse 💬 23 genes, 30 drugs (DrugBank) and 81 diseases |
CACNA1C 2件: CACNA1C, CACNA1D 💬
|
Verapamil Verapamil 💬Glutamatergic synapse
| Verapamil | 058 4件: 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 103 | GnRH secretion 💬 22 genes, 47 drugs (DrugBank) and 56 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Verapamil hydrochloride Verapamil hydrochloride 💬GnRH secretion
| Verapamil | 058 4件: 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 104 | GnRH secretion 💬 22 genes, 47 drugs (DrugBank) and 56 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Verapamil Verapamil 💬GnRH secretion
| Verapamil | 058 4件: 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 105 | GnRH signaling pathway 💬 16 genes, 40 drugs (DrugBank) and 42 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Verapamil hydrochloride Verapamil hydrochloride 💬GnRH signaling pathway
| Verapamil | 058 4件: 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 106 | GnRH signaling pathway 💬 16 genes, 40 drugs (DrugBank) and 42 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Verapamil Verapamil 💬GnRH signaling pathway
| Verapamil | 058 4件: 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 107 | Growth hormone synthesis, secretion and action 💬 23 genes, 49 drugs (DrugBank) and 100 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Verapamil hydrochloride Verapamil hydrochloride 💬Growth hormone synthesis, secretion and action
| Verapamil | 058 4件: 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 108 | Growth hormone synthesis, secretion and action 💬 23 genes, 49 drugs (DrugBank) and 100 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Verapamil Verapamil 💬Growth hormone synthesis, secretion and action
| Verapamil | 058 4件: 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 109 | Hormone signaling 💬 66 genes, 211 drugs (DrugBank) and 153 diseases |
ADRB1 1件: ADRB1 💬Hormone signaling
|
Atenolol Atenolol 💬Hormone signaling
| Atenolol | 167 1件: 167 💬109. Hormone signaling
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 110 | Hormone signaling 💬 66 genes, 211 drugs (DrugBank) and 153 diseases |
ADRB1 1件: ADRB1 💬Hormone signaling
|
Nebivolol Nebivolol 💬Hormone signaling
| Nebivolol | 017 4件: 17, 85, 113, 167 💬110. Hormone signaling
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 111 | Hormone signaling 💬 66 genes, 211 drugs (DrugBank) and 153 diseases |
ADRB1 1件: ADRB1 💬Hormone signaling
|
Nebivolol hydrochloride Nebivolol hydrochloride 💬Hormone signaling
| Nebivolol | 017 4件: 17, 85, 113, 167 💬110. Hormone signaling
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 112 | Hormone signaling 💬 66 genes, 211 drugs (DrugBank) and 153 diseases |
AGTR1 1件: AGTR1 💬Hormone signaling
|
Irbesartan Irbesartan 💬Hormone signaling
| Irbesartan | 066 4件: 66, 167, 168, 222 💬112. Hormone signaling
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 113 | Hormone signaling 💬 66 genes, 211 drugs (DrugBank) and 153 diseases |
AGTR1 1件: AGTR1 💬Hormone signaling
|
Losartan potassium Losartan potassium 💬Hormone signaling
| Losartan | 017 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬113. Hormone signaling
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 114 | Hormone signaling 💬 66 genes, 211 drugs (DrugBank) and 153 diseases |
AGTR1 1件: AGTR1 💬Hormone signaling
|
Losartan Losartan 💬Hormone signaling
| Losartan | 017 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬113. Hormone signaling
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 115 | Hypertrophic cardiomyopathy 💬 27 genes, 57 drugs (DrugBank) and 90 diseases |
ACE 1件: ACE 💬Hypertrophic cardiomyopathy
|
Perindopril erbumine Perindopril erbumine 💬Hypertrophic cardiomyopathy
| Perindopril | 058 4件: 58, 113, 167, 222 💬115. Hypertrophic cardiomyopathy
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 116 | Hypertrophic cardiomyopathy 💬 27 genes, 57 drugs (DrugBank) and 90 diseases |
ACE 1件: ACE 💬Hypertrophic cardiomyopathy
|
Perindopril Perindopril 💬Hypertrophic cardiomyopathy
| Perindopril | 058 4件: 58, 113, 167, 222 💬115. Hypertrophic cardiomyopathy
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 117 | Hypertrophic cardiomyopathy 💬 27 genes, 57 drugs (DrugBank) and 90 diseases |
ACE 1件: ACE 💬Hypertrophic cardiomyopathy
|
Perindopril arginine Perindopril arginine 💬Hypertrophic cardiomyopathy
| Perindopril | 058 4件: 58, 113, 167, 222 💬115. Hypertrophic cardiomyopathy
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 118 | Hypertrophic cardiomyopathy 💬 27 genes, 57 drugs (DrugBank) and 90 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Verapamil hydrochloride Verapamil hydrochloride 💬Hypertrophic cardiomyopathy
| Verapamil | 058 4件: 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 119 | Hypertrophic cardiomyopathy 💬 27 genes, 57 drugs (DrugBank) and 90 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Verapamil Verapamil 💬Hypertrophic cardiomyopathy
| Verapamil | 058 4件: 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 120 | Insulin secretion 💬 15 genes, 48 drugs (DrugBank) and 51 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Verapamil hydrochloride Verapamil hydrochloride 💬Insulin secretion
| Verapamil | 058 4件: 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 121 | Insulin secretion 💬 15 genes, 48 drugs (DrugBank) and 51 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Verapamil Verapamil 💬Insulin secretion
| Verapamil | 058 4件: 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 122 | Long-term potentiation 💬 18 genes, 36 drugs (DrugBank) and 86 diseases |
CACNA1C 1件: CACNA1C 💬Long-term potentiation
|
Verapamil hydrochloride Verapamil hydrochloride 💬Long-term potentiation
| Verapamil | 058 4件: 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 123 | Long-term potentiation 💬 18 genes, 36 drugs (DrugBank) and 86 diseases |
CACNA1C 1件: CACNA1C 💬Long-term potentiation
|
Verapamil Verapamil 💬Long-term potentiation
| Verapamil | 058 4件: 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 124 | MAPK signaling pathway 💬 65 genes, 98 drugs (DrugBank) and 109 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Verapamil hydrochloride Verapamil hydrochloride 💬MAPK signaling pathway
| Verapamil | 058 4件: 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 125 | MAPK signaling pathway 💬 65 genes, 98 drugs (DrugBank) and 109 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Verapamil Verapamil 💬MAPK signaling pathway
| Verapamil | 058 4件: 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 126 | Neuroactive ligand signaling 💬 92 genes, 239 drugs (DrugBank) and 117 diseases |
ADRB1 1件: ADRB1 💬Neuroactive ligand signaling
|
Atenolol Atenolol 💬Neuroactive ligand signaling
| Atenolol | 167 1件: 167 💬126. Neuroactive ligand signaling
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 127 | Neuroactive ligand signaling 💬 92 genes, 239 drugs (DrugBank) and 117 diseases |
ADRB1 1件: ADRB1 💬Neuroactive ligand signaling
|
Nebivolol Nebivolol 💬Neuroactive ligand signaling
| Nebivolol | 017 4件: 17, 85, 113, 167 💬127. Neuroactive ligand signaling
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 128 | Neuroactive ligand signaling 💬 92 genes, 239 drugs (DrugBank) and 117 diseases |
ADRB1 1件: ADRB1 💬Neuroactive ligand signaling
|
Nebivolol hydrochloride Nebivolol hydrochloride 💬Neuroactive ligand signaling
| Nebivolol | 017 4件: 17, 85, 113, 167 💬127. Neuroactive ligand signaling
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 129 | Neuroactive ligand-receptor interaction 💬 158 genes, 364 drugs (DrugBank) and 173 diseases |
ADRB1 1件: ADRB1 💬Neuroactive ligand-receptor interaction
|
Atenolol Atenolol 💬Neuroactive ligand-receptor interaction
| Atenolol | 167 1件: 167 💬129. Neuroactive ligand-receptor interaction
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 130 | Neuroactive ligand-receptor interaction 💬 158 genes, 364 drugs (DrugBank) and 173 diseases |
ADRB1 1件: ADRB1 💬Neuroactive ligand-receptor interaction
|
Nebivolol Nebivolol 💬Neuroactive ligand-receptor interaction
| Nebivolol | 017 4件: 17, 85, 113, 167 💬130. Neuroactive ligand-receptor interaction
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 131 | Neuroactive ligand-receptor interaction 💬 158 genes, 364 drugs (DrugBank) and 173 diseases |
ADRB1 1件: ADRB1 💬Neuroactive ligand-receptor interaction
|
Nebivolol hydrochloride Nebivolol hydrochloride 💬Neuroactive ligand-receptor interaction
| Nebivolol | 017 4件: 17, 85, 113, 167 💬130. Neuroactive ligand-receptor interaction
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 132 | Neuroactive ligand-receptor interaction 💬 158 genes, 364 drugs (DrugBank) and 173 diseases |
AGTR1 1件: AGTR1 💬Neuroactive ligand-receptor interaction
|
Irbesartan Irbesartan 💬Neuroactive ligand-receptor interaction
| Irbesartan | 066 4件: 66, 167, 168, 222 💬132. Neuroactive ligand-receptor interaction
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 133 | Neuroactive ligand-receptor interaction 💬 158 genes, 364 drugs (DrugBank) and 173 diseases |
AGTR1 1件: AGTR1 💬Neuroactive ligand-receptor interaction
|
Losartan potassium Losartan potassium 💬Neuroactive ligand-receptor interaction
| Losartan | 017 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬133. Neuroactive ligand-receptor interaction
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 134 | Neuroactive ligand-receptor interaction 💬 158 genes, 364 drugs (DrugBank) and 173 diseases |
AGTR1 1件: AGTR1 💬Neuroactive ligand-receptor interaction
|
Losartan Losartan 💬Neuroactive ligand-receptor interaction
| Losartan | 017 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬133. Neuroactive ligand-receptor interaction
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 135 | Oxytocin signaling pathway 💬 35 genes, 80 drugs (DrugBank) and 110 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Verapamil hydrochloride Verapamil hydrochloride 💬Oxytocin signaling pathway
| Verapamil | 058 4件: 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 136 | Oxytocin signaling pathway 💬 35 genes, 80 drugs (DrugBank) and 110 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Verapamil Verapamil 💬Oxytocin signaling pathway
| Verapamil | 058 4件: 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 137 | Pathways in cancer 💬 111 genes, 222 drugs (DrugBank) and 146 diseases |
AGTR1 1件: AGTR1 💬Pathways in cancer
|
Irbesartan Irbesartan 💬Pathways in cancer
| Irbesartan | 066 4件: 66, 167, 168, 222 💬137. Pathways in cancer
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 138 | Pathways in cancer 💬 111 genes, 222 drugs (DrugBank) and 146 diseases |
AGTR1 1件: AGTR1 💬Pathways in cancer
|
Losartan potassium Losartan potassium 💬Pathways in cancer
| Losartan | 017 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬138. Pathways in cancer
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 139 | Pathways in cancer 💬 111 genes, 222 drugs (DrugBank) and 146 diseases |
AGTR1 1件: AGTR1 💬Pathways in cancer
|
Losartan Losartan 💬Pathways in cancer
| Losartan | 017 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬138. Pathways in cancer
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 140 | Pathways of neurodegeneration - multiple diseases 💬 63 genes, 138 drugs (DrugBank) and 132 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Verapamil hydrochloride Verapamil hydrochloride 💬Pathways of neurodegeneration - multiple diseases
| Verapamil | 058 4件: 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 141 | Pathways of neurodegeneration - multiple diseases 💬 63 genes, 138 drugs (DrugBank) and 132 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Verapamil Verapamil 💬Pathways of neurodegeneration - multiple diseases
| Verapamil | 058 4件: 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 142 | Phospholipase D signaling pathway 💬 23 genes, 59 drugs (DrugBank) and 82 diseases |
AGTR1 1件: AGTR1 💬Phospholipase D signaling pathway
|
Irbesartan Irbesartan 💬Phospholipase D signaling pathway
| Irbesartan | 066 4件: 66, 167, 168, 222 💬142. Phospholipase D signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 143 | Phospholipase D signaling pathway 💬 23 genes, 59 drugs (DrugBank) and 82 diseases |
AGTR1 1件: AGTR1 💬Phospholipase D signaling pathway
|
Losartan potassium Losartan potassium 💬Phospholipase D signaling pathway
| Losartan | 017 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬143. Phospholipase D signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 144 | Phospholipase D signaling pathway 💬 23 genes, 59 drugs (DrugBank) and 82 diseases |
AGTR1 1件: AGTR1 💬Phospholipase D signaling pathway
|
Losartan Losartan 💬Phospholipase D signaling pathway
| Losartan | 017 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬143. Phospholipase D signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 145 | Prion disease 💬 41 genes, 74 drugs (DrugBank) and 114 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Verapamil hydrochloride Verapamil hydrochloride 💬Prion disease
| Verapamil | 058 4件: 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 146 | Prion disease 💬 41 genes, 74 drugs (DrugBank) and 114 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Verapamil Verapamil 💬Prion disease
| Verapamil | 058 4件: 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 147 | Regulation of lipolysis in adipocytes 💬 13 genes, 71 drugs (DrugBank) and 79 diseases |
ADRB1 1件: ADRB1 💬Regulation of lipolysis in adipocytes
|
Atenolol Atenolol 💬Regulation of lipolysis in adipocytes
| Atenolol | 167 1件: 167 💬147. Regulation of lipolysis in adipocytes
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 148 | Regulation of lipolysis in adipocytes 💬 13 genes, 71 drugs (DrugBank) and 79 diseases |
ADRB1 1件: ADRB1 💬Regulation of lipolysis in adipocytes
|
Nebivolol Nebivolol 💬Regulation of lipolysis in adipocytes
| Nebivolol | 017 4件: 17, 85, 113, 167 💬148. Regulation of lipolysis in adipocytes
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 149 | Regulation of lipolysis in adipocytes 💬 13 genes, 71 drugs (DrugBank) and 79 diseases |
ADRB1 1件: ADRB1 💬Regulation of lipolysis in adipocytes
|
Nebivolol hydrochloride Nebivolol hydrochloride 💬Regulation of lipolysis in adipocytes
| Nebivolol | 017 4件: 17, 85, 113, 167 💬148. Regulation of lipolysis in adipocytes
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 150 | Renin secretion 💬 28 genes, 87 drugs (DrugBank) and 113 diseases |
ACE 1件: ACE 💬Renin secretion
|
Perindopril erbumine Perindopril erbumine 💬Renin secretion
| Perindopril | 058 4件: 58, 113, 167, 222 💬150. Renin secretion
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 151 | Renin secretion 💬 28 genes, 87 drugs (DrugBank) and 113 diseases |
ACE 1件: ACE 💬Renin secretion
|
Perindopril Perindopril 💬Renin secretion
| Perindopril | 058 4件: 58, 113, 167, 222 💬150. Renin secretion
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 152 | Renin secretion 💬 28 genes, 87 drugs (DrugBank) and 113 diseases |
ACE 1件: ACE 💬Renin secretion
|
Perindopril arginine Perindopril arginine 💬Renin secretion
| Perindopril | 058 4件: 58, 113, 167, 222 💬150. Renin secretion
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 153 | Renin secretion 💬 28 genes, 87 drugs (DrugBank) and 113 diseases |
ADRB1 1件: ADRB1 💬Renin secretion
|
Atenolol Atenolol 💬Renin secretion
| Atenolol | 167 1件: 167 💬153. Renin secretion
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 154 | Renin secretion 💬 28 genes, 87 drugs (DrugBank) and 113 diseases |
ADRB1 1件: ADRB1 💬Renin secretion
|
Nebivolol Nebivolol 💬Renin secretion
| Nebivolol | 017 4件: 17, 85, 113, 167 💬154. Renin secretion
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 155 | Renin secretion 💬 28 genes, 87 drugs (DrugBank) and 113 diseases |
ADRB1 1件: ADRB1 💬Renin secretion
|
Nebivolol hydrochloride Nebivolol hydrochloride 💬Renin secretion
| Nebivolol | 017 4件: 17, 85, 113, 167 💬154. Renin secretion
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 156 | Renin secretion 💬 28 genes, 87 drugs (DrugBank) and 113 diseases |
AGTR1 1件: AGTR1 💬Renin secretion
|
Irbesartan Irbesartan 💬Renin secretion
| Irbesartan | 066 4件: 66, 167, 168, 222 💬156. Renin secretion
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 157 | Renin secretion 💬 28 genes, 87 drugs (DrugBank) and 113 diseases |
AGTR1 1件: AGTR1 💬Renin secretion
|
Losartan potassium Losartan potassium 💬Renin secretion
| Losartan | 017 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬157. Renin secretion
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 158 | Renin secretion 💬 28 genes, 87 drugs (DrugBank) and 113 diseases |
AGTR1 1件: AGTR1 💬Renin secretion
|
Losartan Losartan 💬Renin secretion
| Losartan | 017 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬157. Renin secretion
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 159 | Renin secretion 💬 28 genes, 87 drugs (DrugBank) and 113 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Verapamil hydrochloride Verapamil hydrochloride 💬Renin secretion
| Verapamil | 058 4件: 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 160 | Renin secretion 💬 28 genes, 87 drugs (DrugBank) and 113 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Verapamil Verapamil 💬Renin secretion
| Verapamil | 058 4件: 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 161 | Renin secretion 💬 28 genes, 87 drugs (DrugBank) and 113 diseases |
REN 1件: REN 💬Renin secretion
|
Aliskiren Aliskiren 💬Renin secretion
| Aliskiren | 066 3件: 66, 167, 222 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 162 | Renin secretion 💬 28 genes, 87 drugs (DrugBank) and 113 diseases |
REN 1件: REN 💬Renin secretion
|
Aliskiren fumarate Aliskiren fumarate 💬Renin secretion
| Aliskiren | 066 3件: 66, 167, 222 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 163 | Renin-angiotensin system 💬 6 genes, 21 drugs (DrugBank) and 32 diseases |
ACE 1件: ACE 💬Renin-angiotensin system
|
Perindopril erbumine Perindopril erbumine 💬Renin-angiotensin system
| Perindopril | 058 4件: 58, 113, 167, 222 💬163. Renin-angiotensin system
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 164 | Renin-angiotensin system 💬 6 genes, 21 drugs (DrugBank) and 32 diseases |
ACE 1件: ACE 💬Renin-angiotensin system
|
Perindopril Perindopril 💬Renin-angiotensin system
| Perindopril | 058 4件: 58, 113, 167, 222 💬163. Renin-angiotensin system
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 165 | Renin-angiotensin system 💬 6 genes, 21 drugs (DrugBank) and 32 diseases |
ACE 1件: ACE 💬Renin-angiotensin system
|
Perindopril arginine Perindopril arginine 💬Renin-angiotensin system
| Perindopril | 058 4件: 58, 113, 167, 222 💬163. Renin-angiotensin system
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 166 | Renin-angiotensin system 💬 6 genes, 21 drugs (DrugBank) and 32 diseases |
AGTR1 1件: AGTR1 💬Renin-angiotensin system
|
Irbesartan Irbesartan 💬Renin-angiotensin system
| Irbesartan | 066 4件: 66, 167, 168, 222 💬166. Renin-angiotensin system
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 167 | Renin-angiotensin system 💬 6 genes, 21 drugs (DrugBank) and 32 diseases |
AGTR1 1件: AGTR1 💬Renin-angiotensin system
|
Losartan potassium Losartan potassium 💬Renin-angiotensin system
| Losartan | 017 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬167. Renin-angiotensin system
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 168 | Renin-angiotensin system 💬 6 genes, 21 drugs (DrugBank) and 32 diseases |
AGTR1 1件: AGTR1 💬Renin-angiotensin system
|
Losartan Losartan 💬Renin-angiotensin system
| Losartan | 017 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬167. Renin-angiotensin system
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 169 | Renin-angiotensin system 💬 6 genes, 21 drugs (DrugBank) and 32 diseases |
REN 1件: REN 💬Renin-angiotensin system
|
Aliskiren Aliskiren 💬Renin-angiotensin system
| Aliskiren | 066 3件: 66, 167, 222 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 170 | Renin-angiotensin system 💬 6 genes, 21 drugs (DrugBank) and 32 diseases |
REN 1件: REN 💬Renin-angiotensin system
|
Aliskiren fumarate Aliskiren fumarate 💬Renin-angiotensin system
| Aliskiren | 066 3件: 66, 167, 222 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 171 | Retrograde endocannabinoid signaling 💬 34 genes, 65 drugs (DrugBank) and 68 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Verapamil hydrochloride Verapamil hydrochloride 💬Retrograde endocannabinoid signaling
| Verapamil | 058 4件: 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 172 | Retrograde endocannabinoid signaling 💬 34 genes, 65 drugs (DrugBank) and 68 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Verapamil Verapamil 💬Retrograde endocannabinoid signaling
| Verapamil | 058 4件: 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 173 | Salivary secretion 💬 21 genes, 74 drugs (DrugBank) and 72 diseases |
ADRB1 1件: ADRB1 💬Salivary secretion
|
Atenolol Atenolol 💬Salivary secretion
| Atenolol | 167 1件: 167 💬173. Salivary secretion
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 174 | Salivary secretion 💬 21 genes, 74 drugs (DrugBank) and 72 diseases |
ADRB1 1件: ADRB1 💬Salivary secretion
|
Nebivolol Nebivolol 💬Salivary secretion
| Nebivolol | 017 4件: 17, 85, 113, 167 💬174. Salivary secretion
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 175 | Salivary secretion 💬 21 genes, 74 drugs (DrugBank) and 72 diseases |
ADRB1 1件: ADRB1 💬Salivary secretion
|
Nebivolol hydrochloride Nebivolol hydrochloride 💬Salivary secretion
| Nebivolol | 017 4件: 17, 85, 113, 167 💬174. Salivary secretion
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 176 | Serotonergic synapse 💬 39 genes, 122 drugs (DrugBank) and 83 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Verapamil hydrochloride Verapamil hydrochloride 💬Serotonergic synapse
| Verapamil | 058 4件: 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 177 | Serotonergic synapse 💬 39 genes, 122 drugs (DrugBank) and 83 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Verapamil Verapamil 💬Serotonergic synapse
| Verapamil | 058 4件: 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 178 | Taste transduction 💬 28 genes, 91 drugs (DrugBank) and 68 diseases |
CACNA1C 1件: CACNA1C 💬Taste transduction
|
Verapamil hydrochloride Verapamil hydrochloride 💬Taste transduction
| Verapamil | 058 4件: 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 179 | Taste transduction 💬 28 genes, 91 drugs (DrugBank) and 68 diseases |
CACNA1C 1件: CACNA1C 💬Taste transduction
|
Verapamil Verapamil 💬Taste transduction
| Verapamil | 058 4件: 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 180 | Tight junction 💬 13 genes, 36 drugs (DrugBank) and 50 diseases |
CACNA1D 1件: CACNA1D 💬Tight junction
|
Verapamil hydrochloride Verapamil hydrochloride 💬Tight junction
| Verapamil | 058 4件: 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 181 | Tight junction 💬 13 genes, 36 drugs (DrugBank) and 50 diseases |
CACNA1D 1件: CACNA1D 💬Tight junction
|
Verapamil Verapamil 💬Tight junction
| Verapamil | 058 4件: 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 182 | Type II diabetes mellitus 💬 14 genes, 42 drugs (DrugBank) and 94 diseases |
CACNA1C 2件: CACNA1C, CACNA1D 💬
|
Verapamil hydrochloride Verapamil hydrochloride 💬Type II diabetes mellitus
| Verapamil | 058 4件: 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 183 | Type II diabetes mellitus 💬 14 genes, 42 drugs (DrugBank) and 94 diseases |
CACNA1C 2件: CACNA1C, CACNA1D 💬
|
Verapamil Verapamil 💬Type II diabetes mellitus
| Verapamil | 058 4件: 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 184 | Vascular smooth muscle contraction 💬 32 genes, 92 drugs (DrugBank) and 71 diseases |
AGTR1 1件: AGTR1 💬Vascular smooth muscle contraction
|
Irbesartan Irbesartan 💬Vascular smooth muscle contraction
| Irbesartan | 066 4件: 66, 167, 168, 222 💬184. Vascular smooth muscle contraction
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 185 | Vascular smooth muscle contraction 💬 32 genes, 92 drugs (DrugBank) and 71 diseases |
AGTR1 1件: AGTR1 💬Vascular smooth muscle contraction
|
Losartan potassium Losartan potassium 💬Vascular smooth muscle contraction
| Losartan | 017 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬185. Vascular smooth muscle contraction
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 186 | Vascular smooth muscle contraction 💬 32 genes, 92 drugs (DrugBank) and 71 diseases |
AGTR1 1件: AGTR1 💬Vascular smooth muscle contraction
|
Losartan Losartan 💬Vascular smooth muscle contraction
| Losartan | 017 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬185. Vascular smooth muscle contraction
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 187 | Vascular smooth muscle contraction 💬 32 genes, 92 drugs (DrugBank) and 71 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Verapamil hydrochloride Verapamil hydrochloride 💬Vascular smooth muscle contraction
| Verapamil | 058 4件: 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 188 | Vascular smooth muscle contraction 💬 32 genes, 92 drugs (DrugBank) and 71 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Verapamil Verapamil 💬Vascular smooth muscle contraction
| Verapamil | 058 4件: 58, 96, 140, 167 💬
|
Adrenergic signaling in cardiomyocytes
31 genes, 84 drugs (DrugBank) and 76 diseases
AGE-RAGE signaling pathway in diabetic complications
28 genes, 55 drugs (DrugBank) and 96 diseases
Aldosterone synthesis and secretion
20 genes, 41 drugs (DrugBank) and 61 diseases
Alzheimer disease
59 genes, 132 drugs (DrugBank) and 129 diseases
Amphetamine addiction
25 genes, 58 drugs (DrugBank) and 92 diseases
Apelin signaling pathway
20 genes, 36 drugs (DrugBank) and 77 diseases
Arrhythmogenic right ventricular cardiomyopathy
15 genes, 30 drugs (DrugBank) and 28 diseases
Calcium signaling pathway
86 genes, 214 drugs (DrugBank) and 143 diseases
cAMP signaling pathway
66 genes, 189 drugs (DrugBank) and 130 diseases
Carbohydrate digestion and absorption
13 genes, 21 drugs (DrugBank) and 33 diseases
Cardiac muscle contraction
17 genes, 20 drugs (DrugBank) and 25 diseases
Cellular senescence
34 genes, 46 drugs (DrugBank) and 96 diseases
cGMP-PKG signaling pathway
49 genes, 132 drugs (DrugBank) and 124 diseases
Chagas disease
31 genes, 56 drugs (DrugBank) and 87 diseases
Chemical carcinogenesis - receptor activation
39 genes, 135 drugs (DrugBank) and 134 diseases
Cholinergic synapse
32 genes, 64 drugs (DrugBank) and 81 diseases
Circadian entrainment
23 genes, 39 drugs (DrugBank) and 55 diseases
Coronavirus disease - COVID-19
54 genes, 108 drugs (DrugBank) and 105 diseases
Cortisol synthesis and secretion
15 genes, 36 drugs (DrugBank) and 63 diseases
Cushing syndrome
24 genes, 55 drugs (DrugBank) and 71 diseases
Diabetic cardiomyopathy
28 genes, 48 drugs (DrugBank) and 79 diseases
Dilated cardiomyopathy
24 genes, 61 drugs (DrugBank) and 88 diseases
Dopaminergic synapse
31 genes, 102 drugs (DrugBank) and 104 diseases
GABAergic synapse
29 genes, 43 drugs (DrugBank) and 55 diseases
Gap junction
26 genes, 97 drugs (DrugBank) and 82 diseases
Glutamatergic synapse
23 genes, 30 drugs (DrugBank) and 81 diseases
GnRH secretion
22 genes, 47 drugs (DrugBank) and 56 diseases
GnRH signaling pathway
16 genes, 40 drugs (DrugBank) and 42 diseases
Growth hormone synthesis, secretion and action
23 genes, 49 drugs (DrugBank) and 100 diseases
Hormone signaling
66 genes, 211 drugs (DrugBank) and 153 diseases
Hypertrophic cardiomyopathy
27 genes, 57 drugs (DrugBank) and 90 diseases
Insulin secretion
15 genes, 48 drugs (DrugBank) and 51 diseases
Long-term potentiation
18 genes, 36 drugs (DrugBank) and 86 diseases
MAPK signaling pathway
65 genes, 98 drugs (DrugBank) and 109 diseases
Neuroactive ligand signaling
92 genes, 239 drugs (DrugBank) and 117 diseases
Neuroactive ligand-receptor interaction
158 genes, 364 drugs (DrugBank) and 173 diseases
Oxytocin signaling pathway
35 genes, 80 drugs (DrugBank) and 110 diseases
Pathways in cancer
111 genes, 222 drugs (DrugBank) and 146 diseases
Pathways of neurodegeneration - multiple diseases
63 genes, 138 drugs (DrugBank) and 132 diseases
Phospholipase D signaling pathway
23 genes, 59 drugs (DrugBank) and 82 diseases
Prion disease
41 genes, 74 drugs (DrugBank) and 114 diseases
Regulation of lipolysis in adipocytes
13 genes, 71 drugs (DrugBank) and 79 diseases
Renin secretion
28 genes, 87 drugs (DrugBank) and 113 diseases
Renin-angiotensin system
6 genes, 21 drugs (DrugBank) and 32 diseases
Retrograde endocannabinoid signaling
34 genes, 65 drugs (DrugBank) and 68 diseases
Salivary secretion
21 genes, 74 drugs (DrugBank) and 72 diseases
Serotonergic synapse
39 genes, 122 drugs (DrugBank) and 83 diseases
Taste transduction
28 genes, 91 drugs (DrugBank) and 68 diseases
Tight junction
13 genes, 36 drugs (DrugBank) and 50 diseases
Type II diabetes mellitus
14 genes, 42 drugs (DrugBank) and 94 diseases
Vascular smooth muscle contraction
32 genes, 92 drugs (DrugBank) and 71 diseases
